Is oral rapamycin plus bare metal stents a feasible alternative to drug eluting stents to prevent restenosis? A cost effective follow up analysis from the randomized, controlled ORAR III study

被引：0
作者：
Rodriguez, A. E. [1 ]
Mieres, J. [1 ]
Rodriguez-Granillo, A. M. [1 ]
Fernandez-Pereira, C. [1 ]
Felssen, M. R. [1 ]
Curotto, V. [1 ]
Tarragona, S. [1 ]
Mauree, A. [2 ]
Palacios, I. [1 ]
机构：
[1] Otamendi Hosp, Cardiovasc Res Ctr, Buenos Aires, DF, Argentina
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
EUROPEAN HEART JOURNAL | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：396 / 396
页数：1
相关论文
共 50 条
  • [41] Real-world cost-effectiveness of drug-eluting stents vs. bare-metal stents for coronary heart disease-A five-year follow-up study
    Cheng, Hao-Min
    Chiou, Ling-Jan
    Chen, Tzu-Ching
    Sung, Shih-Hsien
    Chen, Chen-Huan
    Lang, Hui-Chu
    HEALTH POLICY, 2019, 123 (02) : 229 - 234
  • [42] Implantation of paclitaxel-eluting stents in saphenous vein grafts in comparison to bare metal stents. Clinical and angiographic follow-up results from a multicenter study
    Hoffmann, R.
    Pohl, T.
    Koester, R.
    Blindt, R.
    Boeckstegers, K. P.
    Heitzer, T.
    EUROPEAN HEART JOURNAL, 2006, 27 : 926 - 926
  • [43] DRUG-ELUTING VERSUS BARE-METAL STENTS IN SAPHENOUS VEIN GRAFT LESIONS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Dominguez, Abel Casso
    Herrera, Yasmin
    Patel, Yash
    Shah, Arpit
    Suleiman, Addi
    Tamis-Holland, Jacqueline E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1194 - 1194
  • [44] Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry
    Rodriguez, Alfredo E.
    Maree, Andrew O.
    Mieres, Juan
    Berrocal, Daniel
    Grinfeld, Liliana
    Fernandez-Pereira, Carlos
    Curotto, Valeria
    Rodriguez-Granillo, Alfredo
    O'Neill, William
    Palacios, Igor F.
    EUROPEAN HEART JOURNAL, 2007, 28 (17) : 2118 - 2125
  • [45] Long-term outcomes of drug-eluting stents versus bare metal stents in saphenous vein graft interventions. Evidence from a meta-analysis of randomized controlled trials
    Nairooz, Ramez
    Saad, Marwan
    Dhillon, Ashwat S.
    Yousaf, Haroon
    Awar, Lena
    Mehra, Anilkumar
    Matthews, Ray, V
    Shavelle, David
    Clavijo, Leonardo
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2018, 19 (08) : 951 - 955
  • [46] Drug-eluting versus bare-metal coronary stents:: 6-month clinical and economic outcomes of a controlled study for the reduction of coronary restenosis
    Brüggenjürgen, BH
    McBride, D
    Willich, SN
    VALUE IN HEALTH, 2005, 8 (03) : 337 - 338
  • [47] Safety and Efficacy of Biodegradable Drug-Eluting vs. Bare Metal Stents: A Meta-Analysis from Randomized Trials
    Yin, Yangguang
    Zhang, Yao
    Zhao, Xiaohui
    PLOS ONE, 2014, 9 (06):
  • [48] Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials
    Biondi-Zoccai, GL
    Agostoni, P
    Abbate, A
    Testa, L
    Burzotta, F
    Lotrionte, M
    Crea, F
    Biasucci, LM
    Vetrovec, GW
    Colombo, A
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 100 (01) : 119 - 123
  • [49] Does Current Evidence Favor Drug-Eluting Stents Over Bare-Metal Stents for Saphenous Venous Graft Interventions? Insights From an Updated Meta-Analysis of Randomized Controlled Trials
    Bavishi, Chirag
    Chatterjee, Saurav
    Stone, Gregg W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (23) : 2456 - 2458
  • [50] Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis
    Nordmann, Alain Joel
    Briel, Matthias
    Bucher, Heiner Claudins
    EUROPEAN HEART JOURNAL, 2006, 27 (23) : 2784 - 2814
12345